A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma

A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), a highly malignant digestive system tumor, poses substantial challenges due to its intricate underlying causes and pronounced post-surgery recurrence. Consequently, the prognosis for HCC remains notably unfavorable. The endorsement of sorafenib and PD-L1 inhibitors fo...

Full description

Bibliographic Details
Main Authors: Julu Huang, Rong Liang, Cheng Lu, Lu Lu, Shuanghang Li, Minchao Tang, Xi Huang, Shilin Huang, Rongyun Mai, Xing Gao, Shizhuo Li, Can Zeng, Yan Lin, Jiazhou Ye
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
advanced hepatocellular carcinoma
tyrosine kinase inhibition
PD-1 inhibitor
curative liver resection
HCC
Online Access:https://www.mdpi.com/1422-0067/24/17/13486

Internet

https://www.mdpi.com/1422-0067/24/17/13486

Similar Items